William Prince

1.7k total citations
43 papers, 1.3k citations indexed

About

William Prince is a scholar working on Infectious Diseases, Molecular Biology and Cellular and Molecular Neuroscience. According to data from OpenAlex, William Prince has authored 43 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 9 papers in Molecular Biology and 9 papers in Cellular and Molecular Neuroscience. Recurrent topics in William Prince's work include HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (9 papers) and Neurobiology and Insect Physiology Research (6 papers). William Prince is often cited by papers focused on HIV/AIDS drug development and treatment (11 papers), HIV Research and Treatment (9 papers) and Neurobiology and Insect Physiology Research (6 papers). William Prince collaborates with scholars based in United Kingdom, United States and Switzerland. William Prince's co-authors include Michael J. Berridge, Howard Rasmussen, B.D. Lindley, Timothy C. Hardman, Susan Fowles, Zrinka Ivezic‐Schoenfeld, M J Berridge, Florian Obermayr, George H. Talbot and Kenneth J. Tack and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Journal of Physiology and Clinical Infectious Diseases.

In The Last Decade

William Prince

43 papers receiving 1.1k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
William Prince United Kingdom	21	365	285	261	183	137	43	1.3k
Gnanasekar Munirathinam United States	26	527 1.4×	96 0.3×	330 1.3×	127 0.7×	61 0.4×	67	1.6k
P Lechat France	19	553 1.5×	179 0.6×	119 0.5×	85 0.5×	26 0.2×	109	1.4k
Mark R. Martzen United States	21	1.3k 3.7×	112 0.4×	371 1.4×	209 1.1×	60 0.4×	34	2.3k
Salvatore Catania Italy	24	281 0.8×	155 0.5×	93 0.4×	229 1.3×	52 0.4×	120	1.8k
B Schmidt Austria	16	345 0.9×	322 1.1×	251 1.0×	134 0.7×	12 0.1×	32	2.0k
Christine Oswald United States	23	760 2.1×	164 0.6×	159 0.6×	114 0.6×	26 0.2×	56	1.6k
Kai Lüersen Germany	24	799 2.2×	60 0.2×	128 0.5×	97 0.5×	51 0.4×	74	1.6k
Takeshi Nara Japan	29	1.0k 2.8×	54 0.2×	185 0.7×	666 3.6×	115 0.8×	106	2.3k
Manuel Campos‐Toimil Spain	28	938 2.6×	123 0.4×	256 1.0×	555 3.0×	184 1.3×	120	2.9k
A.J. Higgins United Kingdom	22	311 0.9×	89 0.3×	107 0.4×	83 0.5×	397 2.9×	62	1.7k

Countries citing papers authored by William Prince

Since Specialization

Citations

This map shows the geographic impact of William Prince's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by William Prince with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites William Prince more than expected).

Fields of papers citing papers by William Prince

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by William Prince. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by William Prince. The network helps show where William Prince may publish in the future.

Co-authorship network of co-authors of William Prince

This figure shows the co-authorship network connecting the top 25 collaborators of William Prince. A scholar is included among the top collaborators of William Prince based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with William Prince. William Prince is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Prince, William, et al.. (2023). Effects of triclabendazole and its metabolite exposure on the heart‐rate–corrected QT intervals: A randomized, placebo‐ and positive‐controlled thorough QT study in healthy individuals. Clinical and Translational Science. 16(10). 1758–1767. 1 indexed citations

Kublin, James G., Sean C. Murphy, Janine Maenza, et al.. (2020). Safety, Pharmacokinetics, and Causal Prophylactic Efficacy of KAF156 in a Plasmodium falciparum Human Infection Study. Clinical Infectious Diseases. 73(7). e2407–e2414. 16 indexed citations

Wicha, Wolfgang W., et al.. (2019). Pharmacokinetics and tolerability of lefamulin following intravenous and oral dosing. Journal of Antimicrobial Chemotherapy. 74(Supplement_3). iii19–iii26. 25 indexed citations

Zeitlinger, Markus, Richard Schwameis, Bernhard Burian, et al.. (2016). Simultaneous assessment of the pharmacokinetics of a pleuromutilin, lefamulin, in plasma, soft tissues and pulmonary epithelial lining fluid. Journal of Antimicrobial Chemotherapy. 71(4). 1022–1026. 55 indexed citations

Prince, William, Zrinka Ivezic‐Schoenfeld, Kenneth J. Tack, et al.. (2013). Phase II Clinical Study of BC-3781, a Pleuromutilin Antibiotic, in Treatment of Patients with Acute Bacterial Skin and Skin Structure Infections. Antimicrobial Agents and Chemotherapy. 57(5). 2087–2094. 88 indexed citations

Wierzbicki, Anthony S., Timothy C. Hardman, & William Prince. (2009). Future Challenges for Microsomal Transport Protein Inhibitors. Current Vascular Pharmacology. 7(3). 277–286. 40 indexed citations

Falcoz, Christine, J.M. Jenkins, Carole Bye, et al.. (2002). Pharmacokinetics of GW433908, a Prodrug of Amprenavir, in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 42(8). 887–898. 42 indexed citations

Moore, Katy H. P., Lindsey Cass, Nigel Dallow, et al.. (2001). Pharmacokinetics and Tolerability of GW420867X, a Nonnucleoside Reverse Transcriptase Inhibitor, following Single Escalating Doses in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 41(10). 1098–1105. 1 indexed citations

Cass, Lindsey, et al.. (2001). The Bioavailability of the Novel Nonnucleoside Reverse Transcriptase Inhibitor GW420867X Is Unaffected by Food in Healthy Male Volunteers. The Journal of Clinical Pharmacology. 41(5). 528–535. 23 indexed citations

10.

Arastéh, Keikawus, Robin Wood, Markus Müller, et al.. (2001). GW420867X Administered to HIV-1-Infected Patients Alone and in Combination with Lamivudine and Zidovudine. HIV Clinical Trials. 2(4). 307–316. 11 indexed citations

11.

Moore, Katy H. P., Lindsey Cass, Nigel Dallow, et al.. (2001). Pharmacokinetics and safety of escalating single and repeat oral doses of GW420867X, a novel non-nucleoside reverse transcriptase inhibitor. European Journal of Clinical Pharmacology. 56(11). 805–811. 7 indexed citations

12.

Thomas, Sarah, Lindsey Cass, William Prince, & M. B. Segal. (2000). Brain and CSF entry of the novel nonnucleoside reverse transcriptase inhibitor, GW420867X. Neuroreport. 11(17). 3811–3815. 3 indexed citations

13.

Chittick, Gregory E., Catherine Gillotin, James A. McDowell, et al.. (1999). Abacavir: Absolute Bioavailability, Bioequivalence of Three Oral Formulations, and Effect of Food. Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy. 19(8). 932–942. 44 indexed citations

14.

Moyle, Graeme, M Youle, Chris Higgs, et al.. (1998). Safety, Pharmacokinetics, and Antiretroviral Activity of the Potent, Specific Human Immunodeficiency Virus Protease Inhibitor Nelfinavir: Results of a Phase I/II Trial and Extended Follow‐up in Patients Infected with Human Immunodeficiency Virus. The Journal of Clinical Pharmacology. 38(8). 736–743. 52 indexed citations

15.

Pue, M. A., et al.. (1994). Linear pharmacokinetics of penciclovir following administration of single oral doses of famciclovir 125, 250, 500 and 750 mg to healthy volunteers. Journal of Antimicrobial Chemotherapy. 33(1). 119–127. 67 indexed citations

16.

Fowles, Susan, et al.. (1994). Lack of a pharmacokinetic interaction between oral famciclovir and allopurinol in healthy volunteers. European Journal of Clinical Pharmacology. 46(4). 355–9. 9 indexed citations

17.

Allen, Graham, et al.. (1994). Metabolic and pharmacokinetic studies following oral administration of¹⁴C-famciclovir to healthy subjects. Xenobiotica. 24(4). 357–368. 40 indexed citations

18.

Lawrence, C.M., et al.. (1989). Systemic absorption of mupirocin after topical application of mupirocin ointment to healthy and dermatologically diseased skin. Journal of Dermatological Treatment. 1(2). 83–86. 3 indexed citations

19.

Prince, William, Michael J. Berridge, & Howard Rasmussen. (1972). Role of Calcium and Adenosine-3′:5′-Cyclic Monophosphate in Controlling Fly Salivary Gland Secretion. Proceedings of the National Academy of Sciences. 69(3). 553–557. 87 indexed citations

20.

Berridge, Michael J. & William Prince. (1971). The electrical response of isolated salivary glands during stimulation with 5-hydroxytryptamine and cyclic AMP. Philosophical transactions of the Royal Society of London. Series B, Biological sciences. 262(842). 111–120. 25 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact